Associated Papers
Platelet protease activated receptor 4 (PAR 4) receptor genotype is associated with an increased risk of preterm birth.
Boelig RC et al.
Journal of Thrombosis and Haemostasis : Jth, 2022
The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older Population.
Selvadurai MV et al.
Thrombosis and Haemostasis, 2022
Cross-ethnic analysis of common gene variants in hemostasis show lopsided representation of global populations in genetic databases.
Osman A et al.
Bmc Medical Genomics, 2022
Determination of PAR4 numbers on the surface of human platelets: no effect of the single nucleotide polymorphism rs773902.
Li S et al.
Platelets, 2021
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition.
Whitley MJ et al.
Journal of Thrombosis and Haemostasis : Jth, 2018
Frequency of PAR4 Ala120Thr variant associated with platelet reactivity significantly varies across sub-Saharan African populations.
Heenkenda MK et al.
Blood, 2018
Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects.
Morikawa Y et al.
Thrombosis Research, 2018
Select a paper to view details